e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 71

Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process

Helena J Teede; Mahnaz Bahri Khomami; Rachel Morman; Joop S E Laven; Anju E. Joham; Michael Costello; Madhuri Patil; D Aled Rees · 2026 · The Lancet

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Polyendocrine metabolic ovarian syndrome (PMOS), previously named polycystic ovary syndrome (PCOS), affects one in eight women. However, the term PCOS is inaccurate, implying pathological ovarian cysts, obscuring diverse endocrine and metabolic features, and contributing to delayed diagnosis, fragmented care, and stigma, while curtailing research and policy framing. Building on an international mandate for change, we outline an unprecedented, rigorous, multistep global consensus process for the name change. Funding and governance were established with engagement of 56 leading academic, clinica

Abstract by Helena J Teede; Mahnaz Bahri Khomami; Rachel Morman; Joop S E Laven; Anju E. Joham; Michael Costello; Madhuri Patil; D Aled Rees, The Lancet (2026) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1016/s0140-6736(26)00717-8